Clinica Chimica Acta 289 (1999) 183-184
www.elsevier.com/locate/clinchim
Author index
Volume
Abraham, P., Wilfred, G., Cathrine, S.P., Oxidative damage to the lipids and proteins of the lungs, testis and kidney of rats during carbon tetra
289, 177
Acebes, C., de la Piedra, C., Traba, M.L., Seibel, M.J., Garcia Martin, C., Armas, J., Herrero Beaumont, G., Biochemical markers of bone chloride intoxication
remodeling and bone sialoprotein in ankylosing 289, 99
Addolorato, G., see Capristo, E spondylitis
289, 11 Akinloye, O., see Olatunde Farombi, E 289, | Akinmoladun, C.O., see Olatunde Farombi, E
289, |
Ando, T., see Gotoh, Y 289, 89
Arienti, G., Saccardi, C., Carlini, E., Verdacchi, R.., Palmerini, C.A., Distribution of lipid and protein in human semen fractions 289, 111 Armas, J., see Acebes, C 289, 99 Asato, T., see Maehira, F 289, 133
‘ampagnoli, M., see Galliano, M apristo, E.,
289, 45 Mingrone, G., De Gaetano, A., Ad dolorato, G., Greco, AV., Gasbarrini, G., A new HPLC method for the direct analysis of tri glycerides of dicarboxylic acids in biological samples 289, 11
‘arlini, E., see Arienti, G 289, 111
‘athrine, S.P., see Abraham, P. 289, 177 Chapman, J.C., see Galliano, M 289, 45 Coe, F.L., see Nakagawa, Y 289, 57
289, 145 289, 11 289, 99 Danielsson, B., see Raghavan, V De Gaetano, A., see Capristo, E de la Piedra, C., see Acebes, C
Eguchi, Y., see Maehira, I 289, 133 Emerole, G.O., see Olatunde Farombi, E 289, |
PII: $009-8981(99)00201-6
289 (1999)
Engler, H., Oettli, R.E., Riesen, W.F., Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross sectional study 289, 159
Fukuoka, M., see Maehira, F 289, 133
Galliano, M., Kragh-Hansen, | Tarnoky, A.l Chapman, J.C., Campagnoli, M., Minchiotti, I Genetic variants showing apparent hot-spots in
289, 45 289, 99 Gasbarrini, G., see Capristo, E 289, 11 Gotoh, K., see Uehara, S$ 289, 33
Gotoh, Y., Okamoto, Y., Uemura, O., Mori, N., Tanaka, S., Ando, T., Nishida, M., Determi nation of age-related changes in human soluble the human serum albumin gene
Garcia Martin, C., see Acebes, ¢
interleukin 2 receptor in body fluids of normal subjects as a control value against disease states 289, 89
Greco, AV., see Capristo, I 289, 11
Handa, H., see Uehara, S 289
Herrero-Beaumont, G., see Acebes, C 289, 99 Hirayama, A., see Uehara, S
Honjo, K., see Uehara, S
Irino, T., see Muramoto, Y 289, 69
Jenkins, M.A., Ratnaike, S., Capillary isoelectric focusing of haemoglobin variants in the clinical laboratory 289, 121
Kodama, H., see Zhang, J 289, 79
Kokcam, I., Nazuroglu, M., Antioxidants and lipid peroxidation status in the blood of patients with
289, 23
psoriasis
Author index
Kragh-Hansen, U., see Galliano, M 289, 45
Ma, D., see Zhang, J 289, 79
Maehira, F.. Miyagi, L., Asato, T., Eguchi, Y Takei, H., Nakatsuki, K., Fukuoka, M., Zaha, F Alterations of protein kinase C, 8-hydroxy
deoxyguanosine, and K-ras oncogene in rat
289, 133
289. 69
lungs exposed to passive smoking Matsushita, M., see Muramoto, Y Meng, Z., see Zhang, J 289, 79 Minchiotti, L., see Galliano, M Mingrone, G., see Capristo, I Miyagi, I., see Maehira, F Mori, N., see Gotoh, Y
Muramoto, Y., Matsushita, M., Irino, T of reaction differences between human mercap
289, 45
Reduction
talbumin and human nonmercaptalbumin mea sured by the bromcresol purple method 289 69
Nakagawa, Y., Coe, F.L., A modified cyanide-nitro prusside method for quantifying urinary cystine concentration that corrects for creatinine interfer ence 289, 57
Nakatsuki, K., see Maehira, I
Nazuroglu, M., see Kékcam I Nishida, M., see Gotoh, Y
289, 133 289, 23 289, 89
Oecttli, R.E., see Engler, H 289, 159 Okamoto, Y., see Gotoh, Y 289. 89 Olatunde Farombi, E., Akinloye, O., Akinmoladun
C.O., Emerole, G.O., Hepatic drug metabolizing enzyme induction and serum triacylglycerol elevation in rats treated with chlordiazepoxide griseofulvin, rifampicin and phenytoin 289, |
Palmerini, C.A., see Arienti, G 289. 111
Raghavan, V.. Ramanathan, K., Sundaram, PV Danielsson, B An enzyme thermistor-based assay for total and free cholesterol 289. 145
289 (1999)
Ramanathan, K., see Raghavan, V 289, 145 Ratnaike, S., see Jenkins, M.A 289, 121 Riesen, W.F., see Engler, H 289, 159 Saccardi, C., see Arienti, G 289. 111 Seibel, M.J., see Acebes, C 289, 99 Sundaram, PV., see Raghavan, V 289, 145
Takei, H., see Maehira, | 289, 133 Tanaka, S., see Gotoh, Y 289, 89 Tarnoky, A.L., see Galliano, M 289, 45 Traba, M.L., see Acebes, ( 289, 99
Uehara, S., Gotoh, K.., Hirayama, A
Handa, H., Honjo, K., Process of carboxylation of glutamic acid residues in the Gla domain of human des-y-carboxyprothrombin 289, 33 Uemura, O., see Gotoh, Y 289, 89
Verdacchi, R., see Arienti, G 289, 111
Wilfred, G., see Abraham, P. 289, 177
Xu, S., see Zhang, J 289, 79
Yamamoto, T., Yonemasu, K
forms of serum immunoglobulin M in a patient Multiple molecular
with Waldenstr6m’s macroglubulinemia 289 173
Yonemasu, K., see Yamamoto, T 289, 173
Zaha, F., see Machira, F 289, 133 Zhang, J.. Meng, Z., Zhang, M., Ma, D
Kodama, H
isolated from anemarrhenae rhizoma on platelet Xu, § Effect of six steroidal saponins
aggregation and hemolysis in human blood 289, 79
Zhang, M see Zhang, J 289, 79
Clinica Chimica Acta 289 (1999)
www.elsevier.com/locate/clinchim
Subject index
Volume 289 (1999)
5,5'-dithiobis(2-nitrobenzoic acid); Serum al Bone sialoprotein; Ankylosing spondylitis; Osteo bumin; Bromcresol purple method; Human met penia; Procollagen | propeptides; Pyridinolines captalbumin; Human nonmercaptalbumin; So Telopeptides 289, 99
dium dodecylsulfate 289, 69
Bromcresol purple method; Serum albumin
$-Hydroxydeoxyguanosine,; Protein kinease C; K Human mercaptalbumin; Human nonmercaptal ras; Lung cancer; Passive smoking 289, 133 bumin; Sodium dodecylsulfate; 5,5'-dithiobis(2
nitrobenzoic acid) 289, 69 Albumin variants: Bisalbuminaemia; Proalbumin
variants; Hypermutability; Functional conse ‘apillary electrophoresis; Clinical laboratory quences of albumin variation 289, 45 Capillary isoelectric focusing: Haemoglobin var
iants 289, 121 Anemarrhenae rhizoma; Platelet aggregation
Hemolysis, Steroidal saponins 289, 79 apillary isoelectric focusing; Capillary electr phoresis; Clinical laboratory
iants 289, 121
Haemoglobin var
Ankylosing spondylitis; Osteopenia; Procollagen |
propeptides Pyridinolines Telopeptides
sialoprotein 289, 99
sone
arbon tetrachloride, Oxidative dam:
— 289, 177
Antioxidants; Psoriasis; Lipid peroxidation; Vita
min E; Beta carotene. 289, 23 ; z
arboxylation; Des-y-carboxyprothrombin; Gla domain; -y-Carboxyglutamic acid; Glutamic acid
Beta carotene; Psoriasis; Lipid peroxidation; Anti wongy ee ee
289, 33 oxidants; Vitamin E 289, 23
Bile; Free cholesterol; Total cholesterol; Enzyme hlordiazepoxide Serum triacylglycerol; Griseo
i he rug metaboliz thermistor; Serum; Flow injection analysis; Gall fulvin; Rifampicin; Phenytoin; Drug metaboliz stones: HDL-C: LDL-C 289 145 ing enzyme induction 289, |
Biochemical bond markers; Thyroid; Pyridinoline Cholesterol; Semen; Prostasomes; Lipid; Protein cross-links; Thyroid dysfunction 289, 159 Phospholipid 289, 111
Bisalbuminaemia; Albumin variants; Proalbumin Clinical laboratory; Capillary electrophoresis;
variants; Hypermutability; Functional conse Capillary isoelectric focusing; Haemoglobin var quences of albumin variation 289, 45 iants 289, 12]
PII: S009-8981(99)00202-8
186 Subject index vol. 289 (1999)
Colorimetry; Cystine; Cystinuria 289, 57
Nephrolithiasis Glutamic acid; Des-y-carboxyprothrombin; Car
Cystine; Cystinuria; Colorimetry 289, 57
boxylation; Gla-domain; -y-Carboxyglutamic acid 289, 33
Nephrolithiasis
Griseofulvin; Serum _ triacylglycerol;
diazepoxide; Rifampicin; Phenytoin;
Cystinuria; Cystine; Colorimetry; Nephrolithiasis metabolizing enzyme induction 289, | 289, 57
Des-y-carboxyprothrombin; Carboxylation; Gla- domain; ‘y-C
289, 33
Chlor- Drug
HDL-C; Free cholesterol; Total cholesterol; En- zyme thermistor;
“arboxyglutamic acid; Glutamic acid
injection 289, 145 Bile; Serum; Flow analysis; Gall stones; LDL-C
Dicarboxylic acids; Dodecanedioic acid; High-per-
Haemoglobin variants; Capillary electrophoresis;
formance liquid chromatography; Sebacic acid;
Triglycerides 289, 11
Clinical laboratory; Capillary isoelectric focusing 289, 121
Dodecanedioic acid; Dicarboxylic acids; High-per- Hemolysis, Steroidal saponins; Anemarrhenae
: rhizoma; Platelet aggregation
formance liquid chromatography; Sebacic acid;
Triglycerides 289, 11
289, 79
Drug metabolizing enzyme induction; Serum
High-performance liquid chromatography; Di- carboxylic acids; Dodecanedioic acid; Sebacic
. ‘ acid; Triglycerides 289, 11
triacylglycerol; Chlordiazepoxide; Griseofulvin;
Rifampicin; Phenytoin 289, |
ELAST*™; Soluble interleukin 2 receptors (sIL-2R);
Human 289, 89
Human mercaptalbumin; Serum albumin; Brom cresol purple method; Human nonmercaptal- bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2-
Enzyme thermistor, Free
nitrobenzoic acid) 289, 69
cholesterol: Total ‘ .
. : Human nonmercaptalbumin; Serum albumin;
cholesterol; Bile; Serum; Flow injection analysis; B ; ’ hod: H '
: _ . “ romcresol purple method; Human mercaptal-
Gall stones; HDL-C; LDL-C 289, 145 — ae on _ P
bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2
+ * . r nitr enZoic ~10 )
Enzyme-linked immunosorbent assay; Walden- obenzoic acid str6m’s macroglubulinemia; Immunoglobulin M;
Nephelometry 289, 173
289, 69
Human; Soluble interleukin 2 receptors (sIL-2R);
ELAST” 289, 89 Flow injection analysis; Free cholesterol; Total
cholesterol; Enzyme thermistor; Bile; Serum;
Gall stones; HDL-C; LDL-C 289, 145 Proalbumin
Hypermutability; Bisalbuminaemia; Albumin var lants;
Bile;
Free cholesterol; Total cholesterol; Enzyme ther-
mustor;
variants; Functional quences of albumin variation 289, 45
Serum; Flow injection analysis;
Gall stones; HDL-C; LDL-C 289, 145
conse-
Immunoglobulin M:; Waldenstrém’s bulinemia;
macroglu- Nephelometry; Enzyme-linked im- munosorbent assay
Functional consequences of albumin variation;
289, 173
Bisalbuminaemia; Albumin variants; Proalbumin K-ras; Protein kinease te.
variants; Hypermutability 289, 45
Gall stones; Free
8-Hydroxy- deoxyguanosine; Lung cancer; Passive smoking 289, 133
cholesterol; Total cholesterol;
Enzyme thermistor, Bile; Serum; Flow injection analysis; HDL-C; LDL-C 289, 145
LDL-C; Free cholesterol; Total cholesterol;
Gla-domain; Des-y-carboxyprothrombin; Carboxy- lation; -y-Carboxyglutamic acid; Glutamic acid 289, 33
En zyme thermistor; Bile; Serum; Flow injection analysis; Gall stones; HDL-C 289, 145
Lipid; Semen; Prostasomes; Protein; Cholesterol;
Phospholipid 289, 111
Subject index vol
Lipid peroxidation; Psoriasis; Antioxidants; Vita min E; Beta carotene. 289, 23
Lung cancer; Protein kinease C; 8-Hydroxy deoxyguanosine; K-ras; Passive smoking 289, 133
Nephelometry; Waldenstr6m’s macroglubulinemia;
Immunoglobulin M; Enzyme-linked immuno sorbent assay 289, 173
Nephrolithiasis; Cystine; Cystinuria; Colorimetry 289, 57
Osteopenia; Ankylosing spondylitis; Procollagen I propeptides; Pyridinolines; Telopeptides; Bone sialoprotein 289, 99
Oxidative damage; Carbon tetrachloride; Rats 289, 177
Passive smoking; Protein kinease C; 8-Hydroxy deoxyguanosine; K-ras; Lung cancer 289, 133
Phenytoin; Serum triacylglycerol; Chlordiazepox ide; Griseofulvin; Rifampicin; Drug metabolizing enzyme induction 289, | 1
Phospholipid; Semen; Prostasomes; Lipid; Protein Cholesterol 289, 111
Platelet aggregation; Anemarrhenae rhizoma;
Hemolysis, Steroidal saponins 289, 79
Proalbumin variants; Bisalbuminaemia; Albumin variants; Hypermutability; Functional conse quences of albumin variation 289, 45
Procollagen I propeptides: Ankylosing spondylitis; Osteopenia; Pyridinolines; Telopep tides; Bone sialoprotein 289, 99
Prostasomes; Semen; Lipid; Protein; Cholesterol;
Phospholipid 289, 111
Protein kinease C; 8-Hydroxydeoxyguanosine; K ras; Lung cancer; Passive smoking 289, 133
Protein; Semen; Prostasomes; Lipid; Cholesterol;
Phospholipid 289, 111
Psoriasis; Lipid peroxidation; Antioxidants; Vita min E; Beta carotene. 289, 23
289 (1999) 187
Pyridinoline cross-links; Thyroid; Biochemical bond markers; Thyroid dysfunction 289, 159
Pyridinolines; Ankylosing spondylitis; Osteopenia;
Procollagen I propeptides; Telopeptides; Bone sialoprotein 289, 99
Rats; Carbon tetrachloride; Oxidative damage 289, 177
Rifampicin; Serum triacylglycerol; Chlordiazepox ide; Griseofulvin; Phenytoin; Drug metabolizing enzyme induction 289, |
Sebacic acid; Dicarboxylic acids; Dodecanedioic acid; High-performance liquid chromatography
Triglycerides 289, 11
Semen, Prostasomes: Lipid; Protein; Cholesterol;
Phospholipid 289, 111
Serum; Free cholesterol; Total cholesterol; Enzyme thermistor; Bile; Flow injection analysis; Gall stones; HDL-C; LDL-C 289, 145
Serum albumin; Bromcresol purple method;
Human mercaptalbumin; Human nonmercaptal bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2 nitrobenzoic acid) 289, 69
Serum triacylglycerol, Chlordiazepoxide; Griseo fulvin; Rifampicin; Phenytoin; Drug metaboliz ing enzyme induction 289, |
Sodium dodecylsulfate; Serum albumin; Brom cresol purple method; Human mercaptalbumin;
Human nonmercaptalbumin; 5,5’-dithiobis(2-ni trobenzoic acid) 289, 69
Soluble interleukin 2 receptors (sIL-2R):
ELAST ; Human 289, 89
relopeptides; Ankylosing spondylitis; Osteopenia;
Procollagen I propeptides; Pyridinolines; Bone sialoprotein 289, 99
Thyroid dysfunction; Thyroid; Biochemical bond markers; Pyridinoline cross-links 289, 159
Thyroid; Biochemical bond markers; Pyridinoline cross-links; Thyroid dysfunction 289, 159
Total cholesterol; Free cholesterol; Enzyme ther mistor; Bile; Serum; Flow injection analysis;
Gall stones; HDL-C; LDL-C 289, 145
Subject index vol
lriglycerides; Dicarboxylic acids; Dodecanedioic acid; High-performance liquid chromatography;
Sebacic acid 289, 11
Vitamin E Psoriasis; Lipid f if peroxidation; Anti oxidants; Beta carotene. 289. s2
289 (1999)
Waldenstrém’s macroglubulinemia; Immuno globulin M; Nephelometry; Enzyme-linked im munosorbent assay 289, 173
y-Carboxyglutamic acid; Des~y-carboxyprothrom bin; Carboxy!ation; Gla-domain; Glutamic acid 289, 33
